Abbott Laboratories Company Profile – Overview
Abbott Laboratories (Abbott) discovers, develops, manufactures and sells a diversified range of healthcare products including branded generic pharmaceuticals, diagnostic systems and tests, and pediatric and adult nutritional products. The company also offers various medical devices including heart failure, electrophysiology, rhythm management, vascular and structural heart devices, and neuromodulation devices. The company also offers minerals and nutrition products and dietary supplements. It has research and development facilities in the US, China, Colombia, India, Singapore, Spain, and the UK; and operates manufacturing facilities across the world. The company markets products in North America, Latin America, the Middle East, Europe, Asia-Pacific and Africa. Abbott is headquartered in Abbott Park, Illinois, the US.
Headquarters
United States of America
Address
100 Abbott Park Rd, Illinois, 60064-3500
Website
www.abbott.com
Telephone
1 224 6676100
No of Employees
115,000
Industry
Medical Equipment
Ticker Symbol & Exchange
ABT (NYSE)
Revenue (2023)
$43.7B
1.3%
EPS
XYZ
Net Income (2023)
XYZ
-2%
Market Cap*
$190.3B
Net Profit Margin (2023)
XYZ
-3.3%
* As of and is in US$
Nội Dung Chính
Abbott Laboratories premium industry data and analytics
1,200
+
A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.
750
+
A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.
130
+
A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.
970
+
Determine Abbott Laboratories go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
640
+
Understand Abbott Laboratories’s commercialized product portfolio to stay one step ahead of the market.
510
+
Install Base provides a holistic and a granular view of the IT product/service deployments from leading vendors. Explore IT infrastructure categories, solution and product/service areas deployed by a prospect.
130
+
Identify which of Abbott Laboratories’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.
130
+
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
70
+
Proactively evaluate Abbott Laboratories’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
60
+
Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Abbott Laboratories’s relevant decision makers and contact details.
2
Track drug and patent expiries along with geographies impacted.
2
Review investigator profiles and find information on trial contacts across Abbott Laboratories, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.
1
Improve competitive bidding with insights into all publicly disclosed IT services contracts for Abbott Laboratories (including IT outsourcing, business process outsourcing, systems integration & consulting and more).
1
IT Client Prospector provides intelligence on Abbott Laboratories’s likely spend across technology areas enabling you to understand the digital strategy.
Products and Services
Products
Brands
–
–
Established Pharmaceutical
Acculink
Gastroenterology Products
FreeStyle
XYZ
XYZ
XYZ
XYZ
XYZ
XYZ
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year
Event
Description
2023
Regulatory Approval
In April, the company announced two new clearances from the U.S. Food and Drug Administration (FDA) for the company’s industry-leading life support system.
2023
Contracts/Agreements
In April, the company entered into a partnership with the Climate Amplified Disease and Epidemics consortium to predict, track and control diseases that may be amplified by climate change.
2023
Regulatory Approval
In March, the company secured an approval from the U.S. Food and Drug Administration for Epic Max stented tissue valve to treat people with aortic regurgitation or stenosis.
Competitor Comparison
Key Parameters
Abbott Laboratories
F. Hoffmann-La Roche Ltd
GSK plc
Medtronic Plc
Eli Lilly and Co
Headquarters
United States of America
Switzerland
United Kingdom
Ireland
United States of America
City
Abbott Park
Basel
Brentford
Dublin
Indianapolis
State/Province
Illinois
–
–
–
Indiana
No. of Employees
115,000
103,613
69,400
95,000
39,000
Entity Type
Public
Public
Public
Public
Public
Executives
Name
Position
Board
Since
Age
Robert B. Ford
Chief Executive Officer; Chairman
Executive Board
2021
49
Robert E. Funck, Jr.
Executive Vice President – Finance; Chief Financial Officer
Senior Management
2020
61
Hubert L. Allen
General Counsel; Secretary; Executive Vice President
Senior Management
2013
57
Daniel Salvadori
Group President- Established Pharmaceuticals and Nutritional Products; Executive Vice President
Senior Management
2021
44
Michael D. Dale
Senior Vice President – Structural Heart
Senior Management
2019
63
Non Dignissim Eros
Proin vel
Convallis
2023
XY
Non Dignissim Eros
Proin vel
Convallis
2023
XY
Non Dignissim Eros
Proin vel
Convallis
2023
XY
